RESUMEN
We compared the immunogenicity of recombinant S. pneumoniae pneumolysin (rPly) when administered with and without Al(OH)3 adjuvant, and evaluated the protective properties of recombinant protein in the active defense experiment. It was shown that double immunization with rPly+Al(OH)3 increases the levels of IgG antibodies in comparison with the control (p<0.01), while triple immunization results in a more significant increase in IgG antibody levels (p<0.001). Double immunization with rPly without Al(OH)3 does not induce a significant increase in antibody levels in comparison with the control, while triple immunization results in a slight but significant increase in antibody levels (p<0.05). The active defense test proved the protective activity of rPly against S. pneumoniae serotype 3 at intranasal infection.
Asunto(s)
Anticuerpos Antibacterianos , Proteínas Bacterianas , Inmunoglobulina G , Proteínas Recombinantes , Streptococcus pneumoniae , Estreptolisinas , Estreptolisinas/inmunología , Estreptolisinas/genética , Proteínas Bacterianas/inmunología , Proteínas Bacterianas/genética , Streptococcus pneumoniae/inmunología , Streptococcus pneumoniae/genética , Animales , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/genética , Anticuerpos Antibacterianos/inmunología , Anticuerpos Antibacterianos/sangre , Inmunoglobulina G/inmunología , Inmunoglobulina G/sangre , Ratones , Infecciones Neumocócicas/inmunología , Infecciones Neumocócicas/prevención & control , Infecciones Neumocócicas/microbiología , Adyuvantes Inmunológicos , Hidróxido de Aluminio/inmunología , Hidróxido de Aluminio/administración & dosificación , Vacunas Neumococicas/inmunología , Vacunas Neumococicas/administración & dosificación , FemeninoRESUMEN
We studied toxicity of recombinant Streptococcus pneumoniae pneumolysin protein in experiments on mice and its cytopathogenic effect on cultures of Vero green monkey kidney cells and human lung carcinoma A549 cells in vitro. In vivo and in vitro experiments proved the absence of compromised toxicity and direct cytopathogenic action of the recombinant protein.
Asunto(s)
Proteínas Bacterianas , Proteínas Recombinantes , Streptococcus pneumoniae , Estreptolisinas , Estreptolisinas/toxicidad , Estreptolisinas/genética , Animales , Proteínas Bacterianas/toxicidad , Proteínas Bacterianas/genética , Chlorocebus aethiops , Ratones , Células Vero , Streptococcus pneumoniae/efectos de los fármacos , Humanos , Proteínas Recombinantes/toxicidad , Proteínas Recombinantes/genética , Células A549RESUMEN
Pneumolysin (Ply) is a target for the development of serotype-independent pneumococcal vaccines, an important condition for the efficacy of which is their ability to activate innate immunity with the subsequent formation of adaptive immunity. In this study, the ability of recombinant full-length Ply (rPly) of pneumococci to induce TLR expression and maturation of dendritic cells generated from mouse bone marrow was evaluated. It was shown that rPly in vitro increased the number of dendritic cells expressing Toll-like receptor 4 (TLR4) on the membrane. rPly caused maturation of dendritic cells generated from mouse bone marrow, which manifested in a decrease in the number of progenitor cells (CD34), an increase in the number of cells expressing the adhesion molecule CD38, costimulatory molecules CD80 and CD86, molecules of terminal differentiation of dendritic cells CD83, as well as molecules of antigenic presentation of the major histocompatibility complex class II.
Asunto(s)
Streptococcus pneumoniae , Estreptolisinas , Receptor Toll-Like 4 , Ratones , Animales , Streptococcus pneumoniae/genética , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/farmacología , Proteínas Bacterianas/metabolismo , Células DendríticasRESUMEN
Immunogenic and protective activity of recombinant pneumolysin was studied in experiments on male BALB/c mice. The mice were immunized intraperitoneally with recombinant pneumolysin sorbed on Al(OH)3 (200 µg per mouse). In 2 weeks after immunization, the isotypes of antibodies to recombinant pneumolysin in the serum of immunized mice were determined by ELISA. The animals were infected with Streptococcus pneumoniae serotype 3. Immunization with recombinant pneumolysin induced the production of anti-pneumolysin antibodies, mainly of IgG1 subisotype. On day 21 after intraperitoneal infection with S. pneumoniae serotype 3 in a dose of 106 microbial cells, the survival rate of animals immunized with recombinant pneumolysin in a dose of 25 µg/mouse was 67% vs. 0% in the control (p<0.001). Recombinant pneumolysin could be considered as a promising protective antigen for inclusion in the serotype-independent vaccine against S. pneumoniae.